| abstract |
Thienotriazolodiazepine compounds of the formula:n wherein each symbol is as defined in the specification and pharmaceutically acceptable salts thereof, and pharmaceutical uses thereof. n Said compounds exhibit PAF-antagonistic activity and are useful for the prevention or treatment of various PAF-induced diseases. |